| pubmed-article:7640212 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C0001815 | lld:lifeskim |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C0017837 | lld:lifeskim |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C0919534 | lld:lifeskim |
| pubmed-article:7640212 | lifeskim:mentions | umls-concept:C0242479 | lld:lifeskim |
| pubmed-article:7640212 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7640212 | pubmed:dateCreated | 1995-9-21 | lld:pubmed |
| pubmed-article:7640212 | pubmed:abstractText | The isoenzyme Mu of glutathione S-transferase (GSTM1) is dominantly inherited, and the prevalence of this isoenzyme in the population is about 60%. The lack of GSTM1 has been linked with cancer risk. The frequency of the phenotypes of this isoenzyme in melanoma (MM) patients (n = 197) is reported here. A significantly higher proportion of individuals in the control group (n = 147) had measurable GSTM1 than MM patients (59.1% vs 42%, P = 0.002); there was a higher proportion of positive phenotypes in general among women than among men. Odds ratio analysis indicated that individuals with this polymorphic variant have an approximately 2-fold risk of developing these cancers. GSTM1 phenotype distribution depends on age, smoking habit and tumour pathology. A group of MM patients with dysplastic naevi was also studied. | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7640212 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7640212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7640212 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7640212 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:7640212 | pubmed:issn | 0007-0920 | lld:pubmed |
| pubmed-article:7640212 | pubmed:author | pubmed-author:MolinaRR | lld:pubmed |
| pubmed-article:7640212 | pubmed:author | pubmed-author:PalouJJ | lld:pubmed |
| pubmed-article:7640212 | pubmed:author | pubmed-author:CastelTT | lld:pubmed |
| pubmed-article:7640212 | pubmed:author | pubmed-author:TriasMM | lld:pubmed |
| pubmed-article:7640212 | pubmed:author | pubmed-author:MoranGG | lld:pubmed |
| pubmed-article:7640212 | pubmed:author | pubmed-author:LafuenteAA | lld:pubmed |
| pubmed-article:7640212 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7640212 | pubmed:volume | 72 | lld:pubmed |
| pubmed-article:7640212 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7640212 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7640212 | pubmed:pagination | 324-6 | lld:pubmed |
| pubmed-article:7640212 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:meshHeading | pubmed-meshheading:7640212-... | lld:pubmed |
| pubmed-article:7640212 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7640212 | pubmed:articleTitle | Phenotype of glutathione S-transferase Mu (GSTM1) and susceptibility to malignant melanoma. MMM group. Multidisciplinary Malignant Melanoma Group. | lld:pubmed |
| pubmed-article:7640212 | pubmed:affiliation | Institute de Salut Pública, Universitat de Barcelona, Spain. | lld:pubmed |
| pubmed-article:7640212 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7640212 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7640212 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7640212 | lld:pubmed |
